Trial reportDeutsches Arzteblatt international2026
Efficacy of an Unguided Digital Intervention for Adults With Attention-Deficit/Hyperactivity Disorder: A Randomized Controlled Trial.
Trial report in Deutsches Arzteblatt international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPsychotherapy for adults with ADHD is still underutilized in Germany and worldwide. Only a small percentage of these patients receive psychotherapy as recommended in the guidelines. Unguided digital interventions may help to lessen this treatment gap.
methodsAn open-label, exploratory randomized controlled trial was conducted (trial registration: DRKS00033320). Adults with confirmed ADHD were recruited at six study centers in Germany, as well as via social media, and were randomly allotted to receive either the intervention (treatment as usual + app) or the control condition (treatment as usual). Data were collected from 2 February to 5 June 2024. The primary endpoint was patients' health-related quality of life (QOL) at 12 weeks. The secondary endpoints included changes in the severity of ADHD symptoms, functional impairment, and symptoms of anxiety or depression. The threshold for statistical significance was set at 10% in view of the exploratory nature of the trial.
results307 subjects were randomized (intervention group: n = 155, control group: 152). 70% were women, 29% men, and 1% was gender diverse; their mean age was 36 years (SD, 9.5). The data were analyzed according to the intention-to-treat principle with a mixed-effects model. The improvement in QOL was greater in the intervention group than in the control group (
conclusionLimitations include that no standardized diagnostics were conducted within the study and that no conclusions can be drawn regarding long-term effects.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.